The effect of urocanic acid on graft rejection in an experimental model of orthotopic corneal transplantation in rabbits

. 1998 Jan ; 236 (1) : 65-8.

Jazyk angličtina Země Německo Médium print

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid09457519

BACKGROUND: Urocanic acid (UCA) is a natural component of the stratum corneum of the skin. It has been described as a photoreceptor for ultraviolet B radiation. UCA is present in the skin as a trans-isomer and undergoes UVB irradiation-dependent isomerization from trans-to cis-isomer. An immunosuppressive effect of irradiated UCA, i.e. a mixture of cis- and trans-isomers, has been demonstrated both in vivo and in vitro. The aim of this study was to evaluate an immunosuppressive effect of irradiated UCA on graft rejection in an experimental model of orthotopic corneal transplantation. METHOD: A commercially available UCA was dissolved in salt solution and irradiated by XeCl excimer laser beam in order to obtain a mixture of cis- and trans-isomers. The immunosuppressive effect of irradiated UCA, compared to controls, unirradiated UCA and salt solution, was evaluated in a high-risk orthotopic corneal transplantation model; the agents were administered subconjunctivally to rabbits. RESULTS: The rejection reaction was observed in all animals. The mean graft survival time in rabbits administered salt solution or unirradiated UCA was 20 days and 22 days, respectively. The irradiated solution of UCA significantly (P < 0.01, Mantel-Cox test) prolonged mean graft survival time to 29 days. CONCLUSION: Subconjunctival administration of irradiated UCA prolonged the graft survival time in comparison with unirradiated UCA or salt solution in recipients in a rabbit transplantation model. Although further studies are necessary, UCA seems to be an effective immunosuppressive drug after corneal transplantation.

Zobrazit více v PubMed

J Invest Dermatol. 1992 Apr;98(4):459-62 PubMed

J Exp Med. 1989 Oct 1;170(4):1117-31 PubMed

Clin Exp Immunol. 1988 Apr;72(1):174-7 PubMed

J Natl Cancer Inst. 1976 Jul;57(1):211-5 PubMed

J Exp Med. 1983 Jul 1;158(1):84-98 PubMed

Invest Ophthalmol Vis Sci. 1984 May;25(5):519-24 PubMed

Invest Ophthalmol Vis Sci. 1985 Apr;26(4):571-4 PubMed

Mol Biol Med. 1991 Feb;8(1):101-16 PubMed

Arch Ophthalmol. 1992 Oct;110(10):1392-403 PubMed

Transpl Int. 1990 May;3(1):8-11 PubMed

J Immunol. 1992 May 15;148(10):3072-8 PubMed

Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2248-53 PubMed

Photodermatol. 1987 Aug;4(4):182-6 PubMed

Exp Dermatol. 1994 Apr;3(2):61-5 PubMed

Cornea. 1984-1985;3(4):231-9 PubMed

Acta Derm Venereol. 1986;66(6):523-6 PubMed

Transplant Proc. 1989 Oct;21(5):3771-2 PubMed

Transplantation. 1993 Jan;55(1):36-43 PubMed

Photodermatol. 1985 Jun;2(3):158-65 PubMed

J Invest Dermatol. 1988 Feb;90(2):92-9 PubMed

Graefes Arch Clin Exp Ophthalmol. 1996 Sep;234(9):586-90 PubMed

Transplantation. 1996 Oct 27;62(8):1050-4 PubMed

Invest Ophthalmol Vis Sci. 1985 Apr;26(4):575-80 PubMed

Photodermatol. 1986 Apr;3(2):98-101 PubMed

Invest Ophthalmol Vis Sci. 1979 Mar;18(3):310-3 PubMed

Dermatol Monatsschr. 1990;176(1):49-54 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...